208 related articles for article (PubMed ID: 31396651)
21. Basal insulin therapy in type 2 diabetes.
Bethel MA; Feinglos MN
J Am Board Fam Pract; 2005; 18(3):199-204. PubMed ID: 15879567
[TBL] [Abstract][Full Text] [Related]
22. [Insulin therapy].
Brunetti P
Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
[TBL] [Abstract][Full Text] [Related]
23. [Long-acting insulins in the treatment of type 2 diabetes and their position in the current treatment algorithm].
Haluzík M
Vnitr Lek; 2017; 63(2):87-92. PubMed ID: 28334539
[TBL] [Abstract][Full Text] [Related]
24. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
Bell DS
Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
[TBL] [Abstract][Full Text] [Related]
25. Premixed insulin analogues for the treatment of diabetes mellitus.
Garber AJ
Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
[TBL] [Abstract][Full Text] [Related]
26. Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.
Esposito K; Giugliano D
Expert Opin Biol Ther; 2012 Feb; 12(2):209-21. PubMed ID: 22214489
[TBL] [Abstract][Full Text] [Related]
27. Insulin analogues and management of diabetes mellitus.
Vaidyanathan B; Menon PS
Indian J Pediatr; 2000 Jun; 67(6):435-41. PubMed ID: 10932964
[TBL] [Abstract][Full Text] [Related]
28. Insulin lispro: its role in the treatment of diabetes mellitus.
Campbell RK; Campbell LK; White JR
Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
[TBL] [Abstract][Full Text] [Related]
29. The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes.
Gallagher A; Butler TJ; Home PD
Diabetes Res Clin Pract; 2007 Jun; 76(3):327-34. PubMed ID: 17092597
[TBL] [Abstract][Full Text] [Related]
30. Biphasic insulin aspart 30: literature review of adverse events associated with treatment.
Davidson J; Vexiau P; Cucinotta D; Vaz J; Kawamori R
Clin Ther; 2005; 27 Suppl B():S75-88. PubMed ID: 16519039
[TBL] [Abstract][Full Text] [Related]
31. Insulin analogues.
Marks J
Postgrad Med; 2002 Nov; 112(5 Suppl Designer):8-12. PubMed ID: 19667599
[TBL] [Abstract][Full Text] [Related]
32. Safety and side effects of the insulin analogues.
Kamal AD; Dixon AN; Bain SC
Expert Opin Drug Saf; 2006 Jan; 5(1):131-43. PubMed ID: 16370962
[TBL] [Abstract][Full Text] [Related]
33. The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?
Maiorino MI; Petrizzo M; Capuano A; Giugliano D; Esposito K
Expert Opin Biol Ther; 2014 Jun; 14(6):799-808. PubMed ID: 24673155
[TBL] [Abstract][Full Text] [Related]
34. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
[TBL] [Abstract][Full Text] [Related]
35. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
Shaefer CF; Anderson J
Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
[TBL] [Abstract][Full Text] [Related]
36. An update on the long-acting insulin analogue glargine.
Thisted H; Johnsen SP; Rungby J
Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
[TBL] [Abstract][Full Text] [Related]
37. [Rapid and ultrarapid insulins: when and how?].
Vuignier Y; Wojtusciszyn A; Kosinski C
Rev Med Suisse; 2022 Jun; 18(784):1110-1114. PubMed ID: 35647749
[TBL] [Abstract][Full Text] [Related]
38. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
Monami M; Marchionni N; Mannucci E
Diabetes Res Clin Pract; 2008 Aug; 81(2):184-9. PubMed ID: 18495286
[TBL] [Abstract][Full Text] [Related]
39. Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
Goldman J; Kapitza C; Pettus J; Heise T
Curr Med Res Opin; 2017 Oct; 33(10):1821-1831. PubMed ID: 28537449
[TBL] [Abstract][Full Text] [Related]
40. [New developments in the treatment and monitoring of type 1 diabetes mellitus].
Otto-Buczkowska E; Jarosz-Chobot P; Tucholski K
Endokrynol Pol; 2008; 59(3):246-53. PubMed ID: 18615401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
